Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / ADR
-
Number of holders
-
823
-
Total 13F shares, excl. options
-
319,727,097
-
Shares change
-
-8,120,753
-
Total reported value, excl. options
-
$13,922,259,966
-
Value change
-
-$354,564,281
-
Put/Call ratio
-
46%
-
Number of buys
-
398
-
Number of sells
-
423
-
Price
-
$43.53
Institutional Holders of GLAXOSMITHKLINE PLC - ADR (GSK) as of Q2 2022
As of 30 Jun 2022 GLAXOSMITHKLINE PLC - ADR (GSK) had 823 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 319,727,097 shares of stock of the company.
Largest 10 holders included Dodge & Cox, Fisher Asset Management, LLC, Capital International Investors, FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, ACADIAN ASSET MANAGEMENT LLC, ARROWSTREET CAPITAL, LIMITED PARTNERSHIP, RENAISSANCE TECHNOLOGIES LLC, JTC Employer Solutions Trustee Ltd, and STATE STREET CORP.
This table shows 823 institutional shareholders of the security as of 30 Jun 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.